Metabolic & digestive pharmaceuticals revenue in Argentina 2017-2022
In the fourth quarter of 2022, the revenue of the metabolic and digestive pharmaceutical industry in Argentina amounted to approximately 44.5 billion Argentine pesos, up from around 38.9 billion pesos reported in the previous quarter. The revenues of this type of pharmaceutical in the South American country showed an overall uptrend since the first quarter of 2018, when it reached about 3.8 billion pesos.